Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07)... ( 9-Year Low in Seasonal Illness affe...)

Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share

Date:1/30/2008

9-Year Low in Seasonal Illness affects sales of Cough and Cold Products

PHOENIX, Jan. 30 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," today announced financial results for its fiscal 2008 third quarter and nine months ended December 31, 2007. Third quarter revenue declined to approximately $30.8 million compared to $36.2 million for the comparable quarter in the prior year. The Company reported a net loss for the quarter of ($635,000), or ($0.07) per diluted share, compared to a net loss of ($463,000), or ($0.05) per diluted share, for the quarter ended December 31, 2006.

For the nine months ended December 31, 2007, the Company reported net sales of $68.0 million, compared to net sales of $78.6 million for the comparable nine months of the prior year. For the nine months ended December 31, 2007 the Company reported net income of approximately $4.7 million, or $0.47 per diluted share, compared to $4.8 million, or $0.48 per diluted share, for the nine months ended December 31, 2006.

Carl Johnson, President and Chief Executive Officer, said, "Our year-to-date results reflect the extreme weakness in the cold season through December. The incidence of colds and flu in the general population during the quarter ended December 31, 2007, was the lowest since Zicam was introduced in 1999 (SDI FAN -- illness tracking data). The low level of illness is reflected in lower consumer consumption of cough and cold products. For the 12 weeks ended December 30, 2007, category retail sales (three-outlet syndicated scanner data) of cough and cold products decreased approximately 5%, comp
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
2. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
3. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
6. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
7. Encision Reports Third Fiscal Quarter Results
8. Zimmer Reports Fourth Quarter and 2007 Financial Results
9. Amylin Pharmaceuticals Reports 2007 Financial Results
10. Cystic Fibrosis Foundation reports upward trend for key health outcomes
11. NBTY Reports First Quarter Results

Post Your Comments:

Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07)...( 9-Year Low in Seasonal Illness affe...),Health